

![]() |
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths |
|
Authors | ![]() | |
Collaboration | With : Usel, Massimo | |
Published in | Annals of oncology. 2012, vol. 23, no. 5, p. 1325-34 | |
Abstract | We describe changes in prostate cancer incidence, survival and mortality and the resulting impact in additional diagnoses and avoided deaths in European areas and the United States. | |
Keywords | Adult — Aged — Aged, 80 and over — Carcinoma/diagnosis/epidemiology/mortality — Cause of Death/trends — Diagnostic Techniques, Endocrine/statistics & numerical data/trends/utilization — Europe/epidemiology — Humans — Incidence — Male — Mass Screening/methods/statistics & numerical data/trends — Medical Oncology/methods/trends — Middle Aged — Prostate-Specific Antigen/analysis — Prostatic Neoplasms/diagnosis/epidemiology/mortality — Survival Analysis — Survival Rate/trends — United States/epidemiology | |
Identifiers | PMID: 21965474 | |
Full text | ||
Structures | ||
Research groups | Epidémiologie des tumeurs (1017) Groupe Bouchardy Magnin Christine (Registre genevois des tumeurs) (532) | |
Citation (ISO format) | NEPPL-HUBER, C et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. In: Annals of oncology, 2012, vol. 23, n° 5, p. 1325-34. doi: 10.1093/annonc/mdr414 https://archive-ouverte.unige.ch/unige:44621 |